Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

SutroVax Stock

Q: How to sell SutroVax stock?

If you hold private company shares of SutroVax - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your SutroVax stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

sutrovax.comHealthcare / BioTech & PharmaFounded: 2013Funding to Date: $173.25MM

Developer of conjugate and novel complex antigen-based vaccines intended to prevent serious infectious diseases. The company's cell-free protein synthesis platform permits site-specific conjugation, enabling the creation of conjugate vaccines with the potential to deliver heightened immunity and broader protection.

Buy or sell SutroVax stockLearn more about SutroVax IPO

OverviewFinancingsValuation

Enterprise Value

Access SutroVax’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like SutroVax.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Grant Pickering

Founder, President, Chief Executive Officer, Director & Board Member

Jeff Fairman Ph.D

Founder & Vice President of Research

Durga Bobba

Chief Business Officer

Elaine Sun

Chief Financial Officer

Aron Stein Ph.D

Vice President, Regulatory Affairs and Quality Assurance

Paul Sauer

Vice President, Process Development & Manufacturing

Board Members

Cristina Ghenoiu Ph.D

Longitude Capital

Moncef Slaoui Ph.D

Medicxi

Patrick Enright

Longitude Capital

Robert Hopfner Ph.D

NFLS - Pivotal

Francesco De Rubertis Ph.D

Medicxi

Kurt Von Emster

Abingworth Management

Nisha Marathe Ph.D

Roche Venture Fund

Peter Hirth Ph.D

Grant Pickering

Heath Lukatch Ph.D

Patrick Heron

Frazier Healthcare Partners

William Newell JD

Sutro Biopharma

SutroVax stock FAQs

Can you buy SutroVax stock?

As SutroVax is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like SutroVax, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy SutroVax stock?

To invest in a private company like SutroVax through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell SutroVax stock?

Yes, you may be able to sell your SutroVax stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell SutroVax stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your SutroVax stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is SutroVax a public company?

No, SutroVax is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is SutroVax’s stock price?

SutroVax is a privately held company and therefore does not have a public stock price. However, you may access SutroVax’s private market stock price with Forge Data.

What is SutroVax’s stock ticker symbol?

SutroVax does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

FINSMES 03/26/2020

SutroVax Raises $110M in Series D Financing | FinSMEs

SutroVax, a Foster City, Calif.-based biopharmaceutical company dedicated to the delivery of novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, closed a $110m Series D financing

FinSMEs 06/07/2018

SutroVax Raises $85M in Series C Financing |FinSMEs

SutroVax, a vaccine platform and development company, closed an $85m Series C financing. The round was led by TPG Growth, with participation from Medicxi and Foresite Capital and Abingworth, Longitude Capital, Frazier Health Care Partners, Pivotal bioVenture Partners, Roche Venture Fund, and CTI Life Sciences Fund

Market Screener 06/07/2018

SutroVax : Announces $85M Series C Financing led by TPG Growth

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.